Severin Schwan

Chief Executive Officer at Roche Holding AG

Severin Schwan

Severin Schwan

Chief Executive Officer at Roche Holding AG

Overview
Career Highlights

F. Hoffmann-La Roche Ltd.
Roche Holding AG
Roche Diagnostics Corp.

RelSci Relationships

2008

Number of Boards

14

Birthday

01/01/1967

Age

54

Number of Awards

1

Contact Data
Trying to get in touch with Severin Schwan? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Severin Schwan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Vice Chairman at ScienceIndustries

Relationship likelihood: Strong

Chairman & Chief Executive Officer of Chugai at Roche Holding AG

Relationship likelihood: Strong

Honorary Professor at University of St. Gallen

Relationship likelihood: Strong

Chief Financial & Information Technology Officer at Roche Holding AG

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Treasurer & Director at Fondation Auxiliaire du Conservatoire botanique de la Ville de

Relationship likelihood: Strong

Head-Group Human Resources at Roche Holding AG

Relationship likelihood: Strong

Former Director at Roche Holding AG

Relationship likelihood: Strong

Director at Vestergaard Frandsen SA

Relationship likelihood: Strong

Senior Adviser at Permira Advisers LLP

Relationship likelihood: Strong

Paths to Severin Schwan
Potential Connections via
Relationship Science
You
Severin Schwan
Chief Executive Officer at Roche Holding AG
Education
Doctorate in Law
Class of 1993

The University of Innsbruck is a public university in Innsbruck, the capital of the Austrian federal state of Tyrol, founded in 1669.

Memberships
Member
2013 - Current

ERT today brings together up to 50 chief executives and chairmen of major multinational companies of European parentage, covering a wide range of industrial sectors. Individuals join at the personal invitation of existing Members, which confers on ERT membership a personal rather than corporate character. ERT Members meet twice a year, in person, at Plenary Sessions. At these Plenary Sessions, Members determine ERT’s work programme, set priorities and establish specialised Working Groups to work on them. Decisions are taken by consensus. The ERT Chairman, two vice-Chairmen, the former ERT Chairman and five other elected Members form the Steering Committee. The Steering Committee reviews ERT activities and makes recommendations to the Plenary Sessions. Each ERT Member nominates an Associate to act as a main point of liaison at working level and to help implement the decisions taken by Members. Much of the work is done by the Working Groups established by the Plenary Sessions. They are chaired by ERT Members and comprise Members, Associates and experts from the companies behind ERT Members. The Working Groups present proposals to the Plenary and take a leading role in the drafting of official ERT messages and positions. The Secretary General is in charge of a small Executive based in Brussels, which coordinates projects, acts as a contact point, provides administrative support and publishes the ERT reports.

Member
2009 - Current

The International Business Leaders Forum is a private company headquartered in London, UK. The firm provides NGO services by companies, foundations and government agencies.

Career History
Chief Executive Officer
2006 - 2008

Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.

Head, Finance & Administration
1995 - 1998
Head of Asia Pacific Region
2004 - 2006

Roche Diagnostics Asia Pacific Pte Ltd. operates as a biotechnology company. Its solutions include serum work area solution, hemostasis testing, hematology, urinalysis, molecular diagnostics, blood safety solutions, and digital services. The company was founded in 1998 and is headquartered in Singapore.

Boards & Committees
Vice Chairman of the Board & Lead Independent Director
2014 - Current

Credit Suisse Group AG is holding company, which engages in the provision of financial services. It operates through the following segments: Swiss Universal Bank; International Wealth Management; Asia Pacific; Global Markets; and Investment Banking and Capital Markets. The Swiss Universal Bank segment offers comprehensive advice and financial solutions to private, corporate, and institutional clients in Switzerland. The International Wealth Management segment gives advisory services, and tailored investment and financing solutions to wealthy private clients and external asset managers in Europe, the Middle East, Africa, and Latin America. The Asia Pacific segment comprises of wealth management, financing, and underwriting activities. The Global Market segment delivers securities sales, trading and execution, prime brokerage, and comprehensive investment research. The Investment Banking and Capital Markets segment covers investment banking services to corporations, financial institutions, and financial sponsors. The company was founded by Alfred Escher on July 5, 1856 and is headquartered in Zurich, Switzerland.

Member, Board of Directors
1993 - Current

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Chairman, Board of Directors
Current

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer, Kenneth B. Lee and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Awards & Honors
Rank #48
2013
Fortune Magazine - Business Person of the Year
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Severin Schwan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Severin Schwan's profile does not indicate a business or promotional relationship of any kind between RelSci and Severin Schwan.